Therapy with somatostatin analogs in patients with graves' ophthalmopathy and positive octreoscan;Therapie der endokrinen Orbitopathie mit Somatostatin-Analoga bei Patienten mit positivem Octreo-Scan

Acta Medica Austriaca

Volumn 28, Issue 4, 2001, Pages 99-101

  Pichler, R ^a   Maschek, W ^a   Holzinger, C ^b  

^a Aus dem Institut für Nuklearmedizin und Endokrinologie und der   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Endocrine orbitopathy; Graves' disease; Octreoscan; Somatostatin analogues

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; HORMONE; OCTREOTIDE;

ADULT; ARTICLE; FEMALE; GRAVES DISEASE; HUMAN; MALE; SCINTILLATION CAMERA; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ADULT; FEMALE; GAMMA CAMERAS; GRAVES DISEASE; HORMONES; HUMANS; MALE; OCTREOTIDE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0035236768     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2571.2001.01024.x     Document Type: Article

References (1)

1. Bahn RS, Dutton CM, Joba W, Heufelder AE: Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin. Thyroid 1998;8:193-196.